Arrowstreet Capital, Limited Partnership Dexcom Inc Transaction History

Arrowstreet Capital, Limited Partnership

$121 Billion
Q3 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Dexcom Inc stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 81,425 shares of DXCM stock, worth $6.18 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,425

Previous 54,966 48.14%

Holding current value

$6.18 Million

Previous $6.23 Million 12.44%

% of portfolio

0.0%

Previous 0.01%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$64.0 - $116.06 $1.69 Million - $3.07 Million	26,459 Added 48.14%	81,425 $5.46 Million
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $6.06 Million - $7.72 Million	54,966 New	54,966 $6.23 Million
Q3 2023 Nov 14, 2023	SELL	$86.06 - $137.93 $76.9 Million - $123 Million	-893,704 Reduced 92.75%	69,894 $6.52 Million
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $11.5 Million - $13.4 Million	-102,461 Reduced 9.61%	963,598 $124 Million
Q1 2023 May 15, 2023	BUY	$104.0 - $122.92 $20.4 Million - $24.1 Million	195,812 Added 22.5%	1,066,059 $124 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $66 Million - $95.2 Million	776,111 Added 824.46%	870,247 $98.5 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $1.73 Million - $2.13 Million	-22,602 Reduced 19.36%	94,136 $7.58 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $7.94 Million - $15.5 Million	116,738 New	116,738 $8.7 Million
Q1 2022 May 13, 2022	SELL	$94.08 - $130.2 $39.7 Million - $54.9 Million	-421,504 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $54.7 Million - $68.6 Million	421,504 New	421,504 $226 Million
Q1 2021 May 14, 2021	SELL	$84.79 - $104.74 $2.64 Million - $3.26 Million	-31,083 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$78.0 - $104.5 $1.07 Million - $1.43 Million	13,719 Added 79.01%	31,083 $11.5 Million
Q3 2020 Nov 12, 2020	BUY	$95.51 - $112.95 $1.66 Million - $1.96 Million	17,364 New	17,364 $7.16 Million
Q2 2020 Aug 12, 2020	SELL	$62.68 - $105.34 $2.43 Million - $4.09 Million	-38,788 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$47.79 - $75.63 $1.85 Million - $2.93 Million	38,788 New	38,788 $10.4 Million

Others Institutions Holding DXCM

# of Institutions

1,013

Shares Held

351M

Call Options Held

5.51M

Put Options Held

5.6M

View Full List

About DEXCOM INC

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $29.3B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

More about DXCM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Dexcom Inc Transaction History